Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AVIR
NGNE
Add up to 3 more stocks
AVIR
Atea Pharmaceuticals, Inc.
-1.49%
$5.05-0.08Delayed quote: Oct 6, 2026, 2:35 PM EDT
Market Cap
$404.43M
52W Range
$2.87 - $6.45
NGNE
Neurogene Inc.
-2.32%
$25.86-0.61Delayed quote: Oct 6, 2026, 2:34 PM EDT
Market Cap
$408.60M
52W Range
$15.93 - $43.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.98 | 1.88 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -81.0% | -51.2% |
| ROA | -71.2% | -45.5% |
| ROIC | -89.9% | -54.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 8.13 | 10.64 |
| Quick Ratio | 8.13 | 10.64 |
| Debt/Equity | 0.00 | 0.04 |
| Interest Coverage | N/A | -20641.60 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.